AZENTA INC (AZTA) Fundamental Analysis & Valuation
NASDAQ:AZTA • US1143401024
Current stock price
24.32 USD
-0.63 (-2.53%)
At close:
24.32 USD
0 (0%)
After Hours:
This AZTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AZTA Profitability Analysis
1.1 Basic Checks
- AZTA had positive earnings in the past year.
- In the past year AZTA had a positive cash flow from operations.
- In multiple years AZTA reported negative net income over the last 5 years.
- Of the past 5 years AZTA 4 years had a positive operating cash flow.
1.2 Ratios
- AZTA's Return On Assets of -2.79% is in line compared to the rest of the industry. AZTA outperforms 57.89% of its industry peers.
- AZTA has a Return On Equity of -3.37%. This is in the better half of the industry: AZTA outperforms 61.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.79% | ||
| ROE | -3.37% | ||
| ROIC | N/A |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of AZTA (44.59%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of AZTA has remained more or less at the same level.
- The Profit Margin and Operating Margin are not available for AZTA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.59% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
2. AZTA Health Analysis
2.1 Basic Checks
- AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, AZTA has more shares outstanding
- The number of shares outstanding for AZTA has been reduced compared to 5 years ago.
- Compared to 1 year ago, AZTA has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 3.42 indicates that AZTA is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 3.42, AZTA is in the better half of the industry, outperforming 70.18% of the companies in the same industry.
- There is no outstanding debt for AZTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.42 |
ROIC/WACCN/A
WACC10.94%
2.3 Liquidity
- AZTA has a Current Ratio of 2.92. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
- AZTA has a Current ratio (2.92) which is comparable to the rest of the industry.
- AZTA has a Quick Ratio of 2.61. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
- AZTA's Quick ratio of 2.61 is in line compared to the rest of the industry. AZTA outperforms 57.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.92 | ||
| Quick Ratio | 2.61 |
3. AZTA Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 14.89% over the past year.
- AZTA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.04% yearly.
- AZTA shows a decrease in Revenue. In the last year, the revenue decreased by -8.40%.
- Measured over the past years, AZTA shows a quite strong growth in Revenue. The Revenue has been growing by 8.86% on average per year.
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
3.2 Future
- Based on estimates for the next years, AZTA will show a very strong growth in Earnings Per Share. The EPS will grow by 27.49% on average per year.
- The Revenue is expected to grow by 5.37% on average over the next years.
EPS Next Y50.47%
EPS Next 2Y43.51%
EPS Next 3Y35.52%
EPS Next 5Y27.49%
Revenue Next Year5.15%
Revenue Next 2Y5.46%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. AZTA Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 45.04 indicates a quite expensive valuation of AZTA.
- Compared to the rest of the industry, the Price/Earnings ratio of AZTA indicates a somewhat cheap valuation: AZTA is cheaper than 61.40% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.53. AZTA is valued rather expensively when compared to this.
- With a Price/Forward Earnings ratio of 22.28, AZTA is valued on the expensive side.
- 77.19% of the companies in the same industry are more expensive than AZTA, based on the Price/Forward Earnings ratio.
- Compared to an average S&P500 Price/Forward Earnings ratio of 37.95, AZTA is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.04 | ||
| Fwd PE | 22.28 |
4.2 Price Multiples
- AZTA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AZTA is cheaper than 78.95% of the companies in the same industry.
- 63.16% of the companies in the same industry are more expensive than AZTA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.22 | ||
| EV/EBITDA | 16.7 |
4.3 Compensation for Growth
- AZTA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- AZTA's earnings are expected to grow with 35.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2Y43.51%
EPS Next 3Y35.52%
5. AZTA Dividend Analysis
5.1 Amount
- No dividends for AZTA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AZTA Fundamentals: All Metrics, Ratios and Statistics
24.32
-0.63 (-2.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)05-05 2026-05-05/amc
Inst Owners116.07%
Inst Owner Change0.01%
Ins Owners0.69%
Ins Owner Change12.39%
Market Cap1.12B
Revenue(TTM)594.95M
Net Income(TTM)-57.85M
Analysts77.14
Price Target37.74 (55.18%)
Short Float %11.64%
Short Ratio5.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.65%
Min EPS beat(2)-35.95%
Max EPS beat(2)8.65%
EPS beat(4)2
Avg EPS beat(4)-5.26%
Min EPS beat(4)-35.95%
Max EPS beat(4)36.22%
EPS beat(8)6
Avg EPS beat(8)46.66%
EPS beat(12)9
Avg EPS beat(12)140.12%
EPS beat(16)13
Avg EPS beat(16)118.13%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)1
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)-1.08%
PT rev (1m)-1.89%
PT rev (3m)-4.78%
EPS NQ rev (1m)-0.49%
EPS NQ rev (3m)-24.05%
EPS NY rev (1m)-0.71%
EPS NY rev (3m)-0.16%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.04 | ||
| Fwd PE | 22.28 | ||
| P/S | 1.88 | ||
| P/FCF | 36.22 | ||
| P/OCF | 17.95 | ||
| P/B | 0.65 | ||
| P/tB | 1.22 | ||
| EV/EBITDA | 16.7 |
EPS(TTM)0.54
EY2.22%
EPS(NY)1.09
Fwd EY4.49%
FCF(TTM)0.67
FCFY2.76%
OCF(TTM)1.35
OCFY5.57%
SpS12.92
BVpS37.23
TBVpS19.88
PEG (NY)0.89
PEG (5Y)N/A
Graham Number21.2685 (-12.55%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.79% | ||
| ROE | -3.37% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.59% | ||
| FCFM | 5.2% |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 55.45% | ||
| Cap/Sales | 5.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 156.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.92 | ||
| Quick Ratio | 2.61 | ||
| Altman-Z | 3.42 |
F-Score5
WACC10.94%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
EPS Next Y50.47%
EPS Next 2Y43.51%
EPS Next 3Y35.52%
EPS Next 5Y27.49%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
Revenue Next Year5.15%
Revenue Next 2Y5.46%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%
EBIT growth 1Y71.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year493.88%
EBIT Next 3Y107.95%
EBIT Next 5YN/A
FCF growth 1Y-4.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.01%
OCF growth 3YN/A
OCF growth 5Y13.75%
AZENTA INC / AZTA Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for AZENTA INC?
ChartMill assigns a fundamental rating of 5 / 10 to AZTA.
What is the valuation status for AZTA stock?
ChartMill assigns a valuation rating of 5 / 10 to AZENTA INC (AZTA). This can be considered as Fairly Valued.
Can you provide the profitability details for AZENTA INC?
AZENTA INC (AZTA) has a profitability rating of 3 / 10.
How financially healthy is AZENTA INC?
The financial health rating of AZENTA INC (AZTA) is 8 / 10.
What is the expected EPS growth for AZENTA INC (AZTA) stock?
The Earnings per Share (EPS) of AZENTA INC (AZTA) is expected to grow by 50.47% in the next year.